54575-217 : Rhizopus Nigricans 1 g/20ml Percutaneous; Subcutaneous Injection, Solution
NDC: | 54575-217 |
Labeler: | Allergy Laboratories, Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | Rhizopus Nigricans |
Dosage Form: | Percutaneous; Subcutaneous Injection, Solution |
Application #: | BLA101376 |
Rev. Date: |
NDC Package Codes:
- 54575-217-02: 2 ML IN 1 VIAL, MULTI‑DOSE (54575‑217‑02)
- 54575-217-10: 10 ML IN 1 VIAL, MULTI‑DOSE (54575‑217‑10)
- 54575-217-30: 30 ML IN 1 VIAL, MULTI‑DOSE (54575‑217‑30)
- 54575-217-50: 50 ML IN 1 VIAL, MULTI‑DOSE (54575‑217‑50)
Active Ingredients:
- Rhizopus Stolonifer
Dosage Strength:
- 1 g/20mL
Pharmaceutical Classes:
- Non-Standardized Fungal Allergenic Extract [EPC]
- Increased Histamine Release [PE]
- Cell-mediated Immunity [PE]
- Increased IgG Production [PE]
- Fungal Proteins [CS]
- Allergens [CS]
Related Products:
Based on records with the same trade name.- 49643-170 Rhizopus Nigricans .1 g/ml Percutaneous; Subcutaneous Liquid by Allermed Laboratories, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 54575-216Next: 54575-218 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.